Literature DB >> 11722813

Antimicrobial Resistance in Vulvovaginitis.

Jack D. Sobel1.   

Abstract

Although antimicrobial resistance has had an enormous impact on selection and utilization of antibiotics in virtually all aspects of clinical medicine, both inpatient and community based, little attention has been directed at antimicrobial resistance occurring in vaginal infections. Little evidence exists that frequent relapses of bacterial vaginosis or vulvovaginal candidiasis are due to antimicrobial resistance. Similarly, metronidazole-resistant trichomoniasis remains rare. Nevertheless, abuse of over-the-counter antimycotics, as well as widespread prescription of systemic oral azoles, could result in spread of azole-resistant Candida albicans, and even more likely could lead to an increase in non-albicans Candida species with intrinsic azole resistance. Problematic species include Candida glabrata and rarely Candida krusei.

Entities:  

Year:  2001        PMID: 11722813     DOI: 10.1007/s11908-001-0093-5

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN: 1523-3847            Impact factor:   3.725


  22 in total

1.  Prevalence of 5-nitroimidazole-resistant trichomonas vaginalis in Oviedo, Spain.

Authors:  S Pérez; A Fernández-Verdugo; F Pérez; F Vázquez
Journal:  Sex Transm Dis       Date:  2001-02       Impact factor: 2.830

2.  Managing Resistant Trichomonas Vaginitis.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-10       Impact factor: 3.725

Review 3.  Resistance of Candida species to fluconazole.

Authors:  J H Rex; M G Rinaldi; M A Pfaller
Journal:  Antimicrob Agents Chemother       Date:  1995-01       Impact factor: 5.191

Review 4.  Clinical pharmacology of systemic antifungal agents: a comprehensive review of agents in clinical use, current investigational compounds, and putative targets for antifungal drug development.

Authors:  A H Groll; S C Piscitelli; T J Walsh
Journal:  Adv Pharmacol       Date:  1998

5.  Difficult-to-treat trichomoniasis: results with paromomycin cream.

Authors:  P Nyirjesy; J D Sobel; M V Weitz; D J Leaman; S P Gelone
Journal:  Clin Infect Dis       Date:  1998-04       Impact factor: 9.079

6.  The evolution of Candida species and fluconazole susceptibility among oral and vaginal isolates recovered from human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women.

Authors:  J D Sobel; S E Ohmit; P Schuman; R S Klein; K Mayer; A Duerr; J A Vazquez; A Rampalo
Journal:  J Infect Dis       Date:  2001-01-15       Impact factor: 5.226

7.  Tinidazole therapy for metronidazole-resistant vaginal trichomoniasis.

Authors:  J D Sobel; P Nyirjesy; W Brown
Journal:  Clin Infect Dis       Date:  2001-09-17       Impact factor: 9.079

8.  Does long-term itraconazole prophylaxis result in in vitro azole resistance in mucosal Candida albicans isolates from persons with advanced human immunodeficiency virus infection? The National Institute of Allergy and Infectious Diseases Mycoses study group.

Authors:  M Goldman; G A Cloud; M Smedema; A LeMonte; P Connolly; D S McKinsey; C A Kauffman; B Moskovitz; L J Wheat
Journal:  Antimicrob Agents Chemother       Date:  2000-06       Impact factor: 5.191

Review 9.  Antifungal drug resistance in pathogenic fungi.

Authors:  H Vanden Bossche; F Dromer; I Improvisi; M Lozano-Chiu; J H Rex; D Sanglard
Journal:  Med Mycol       Date:  1998       Impact factor: 4.076

10.  Comparative in vitro activity of antimycotic agents against pathogenic vaginal yeast isolates.

Authors:  M E Lynch; J D Sobel
Journal:  J Med Vet Mycol       Date:  1994
View more
  2 in total

1.  Prevalence and Antimicrobial Susceptibility Profiles of Microorganisms Associated with Lower Reproductive Tract Infections in Women from Southern Poland-Retrospective Laboratory-Based Study.

Authors:  Jadwiga Wójkowska-Mach; Monika Pomorska-Wesołowska; Małgorzata Romanik; Dorota Romaniszyn
Journal:  Int J Environ Res Public Health       Date:  2021-01-05       Impact factor: 3.390

Review 2.  Use of locally delivered dequalinium chloride in the treatment of vaginal infections: a review.

Authors:  Werner Mendling; Ernst Rainer Weissenbacher; Stefan Gerber; Valdas Prasauskas; Philipp Grob
Journal:  Arch Gynecol Obstet       Date:  2015-10-27       Impact factor: 2.344

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.